Blood Coagulation and Fibrinolysis, 1473-5733

Tidskrift

Fler filtreringsmöjligheter
  1. 2021
  2. 2020
  3. A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family

    Marcus Fager Ferrari, Eva Leinoe, Maria Rossing, Eva Norström & Eva Zetterberg, 2020, I: Blood Coagulation and Fibrinolysis. 31, 7, s. 481-484

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Von Willebrand factor alloantibodies in type 3 von Willebrand disease

    Barbara Faganel Kotnik, Karin Strandberg, Maruša Debeljak, Lidija Kitanovski, Janez Jazbec, Majda Benedik-Dolničar & Alenka Trampuš Bakija, 2020, I: Blood Coagulation and Fibrinolysis. 31, 1, s. 77-79 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2016
  6. Malignancies in Swedish persons with haemophilia: a longitudinal registry study

    Susanna Lövdahl, K M Henriksson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2016 sep, I: Blood Coagulation and Fibrinolysis. 27, 6, s. 631–636

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. The effect of Nordic Walking on joint status, quality of life, physical ability, exercise capacity and pain in adult persons with haemophilia

    Maryem Salim, Elisabeth Brodin, Yvonne Spaals-Abrahamsson, Erik Berntorp & Eva Zetterberg, 2016 jun 1, I: Blood Coagulation and Fibrinolysis. 27, 4, s. 467-472 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Pain and pain management in haemophilia

    Günter Auerswald, Gerry Dolan, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Thierry Lambert & Silva Zupančić Šalek, 2016, I: Blood Coagulation and Fibrinolysis. 27, 8, s. 845-854

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  9. 2015
  10. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.

    Elena Holm, Thomas C Abshire, Joel Bowen, M A Teresa Álvarez, Paula Bolton-Maggs, Manuel Carcao, Augusto B Federici, Joan Cox Gill, Susan Halimeh, Christine Kempton, Nigel S Key, Peter Kouides, Alice Lail, Andrea Landorph, Frank Leebeek, Michael Makris, Pier Mannucci, Eveline P Mauser-Bunschoten, Diane Nugent, Leonard A Valentino & 2 andra, Rochelle Winikoff & Erik Berntorp, 2015, I: Blood Coagulation and Fibrinolysis. 26, 4, s. 383-388

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Rationale for individualizing haemophilia care.

    Benny Sørensen, Günter Auerswald, Gary Benson, Ivo Elezović, Markus Felder, Thierry Lambert, Massimo Morfini, Eduardo Remor, Peter Salaj, Elena Santagostino, Silva Z Salek & Rolf Ljung, 2015, I: Blood Coagulation and Fibrinolysis. 26, 8, s. 849-857

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  12. 2014
  13. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.

    Anna Olsson, Margareta Hellgren, Erik Berntorp, Rolf Ljung & Fariba Baghaei, 2014, I: Blood Coagulation and Fibrinolysis. 25, 5, s. 471-475

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2011
  15. Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays.

    Donald F Brophy, Erika J Martin, J Christian Barrett, Melinda E Nolte, Janice G Kuhn, Ulla Hedner & Mirella Ezban, 2011, I: Blood Coagulation and Fibrinolysis. 22, s. 541-546

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Physical activity and joint function in adults with severe haemophilia on long-term prophylaxis.

    Mohamed Khawaji, Jan Astermark, Kristina Åkesson & Erik Berntorp, 2011, I: Blood Coagulation and Fibrinolysis. 22, 1, s. 50-55

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 2010
  18. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.

    Erik Berntorp, Sandra Figueiredo, Lucimara Futema, Katharina Pock, Sigurd Knaub, Olaf Walter, Laurenz Trawnicek & Jürgen Römisch, 2010, I: Blood Coagulation and Fibrinolysis. 21, s. 577-583

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2008
  20. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis

    Maria A. Eriksson, Eva Rask, Owe Johnson, Kjell Carlstrom, Bo Ahrén, Mats Eliasson, Kurt Boman & Stefan Soderberg, 2008, I: Blood Coagulation and Fibrinolysis. 19, 7, s. 625-632

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 2007
  22. Monitoring fondaparinux with the Sonoclot

    Caroline Nilsson & Martin Engström, 2007, I: Blood Coagulation and Fibrinolysis. 18, 7, s. 619-622

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2006
  24. Ethanol impairs coagulation and fibrinolysis in whole blood: a study performed with rotational thromboelastometry.

    Martin Engström, Ulf Schött & Peter Reinstrup, 2006, I: Blood Coagulation and Fibrinolysis. 17, 8, s. 661-665

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2005
  26. Cost effectiveness of haemophilia treatment: a cross-national assessment.

    Barbara Lippert, Karin Berger, Erik Berntorp, Paul Giangrande, Marijke van den Berg, Wolfgang Schramm & Uwe Siebert, 2005, I: Blood Coagulation and Fibrinolysis. 16, 7, s. 477-485

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Long-term prophylaxis in von Willebrand disease

    Erik Berntorp & P Petrini, 2005, I: Blood Coagulation and Fibrinolysis. 16, Suppl 1, s. S23-S26

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Normal D-dimer concentration is a common finding in symptomatic outpatients with distal deep vein thrombosis.

    Cecilia Jennersjö, Inger Fagerberg, Sven Karlander & Tomas Lindahl, 2005, I: Blood Coagulation and Fibrinolysis. 16, 7, s. 517-523

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2004
  30. Activation of fibrinolysis and coagulation in non-occlusive intestinal ischaemia in a pig model

    Stefan Acosta, Torbjorn K. Nilsson, David Bergqvist & Martin Björck, 2004, I: Blood Coagulation and Fibrinolysis. 15, 1, s. 69-76

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency.

    Carla Vossen, Karin Strandberg, Johan Stenflo, Frits Rosendaal, Peter Callas, George Long & Edwin Bovill, 2004, I: Blood Coagulation and Fibrinolysis. 15, 7, s. 573-576

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. 2003
  33. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

    R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, C Janbon, A Leizorovicz, Carl-Gustav Olsson & AGG Turpie, 2003, I: Blood Coagulation and Fibrinolysis. 14, 4, s. 341-346

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent.

    Joanna Webb, Anna Blom & Björn Dahlbäck, 2003, I: Blood Coagulation and Fibrinolysis. 14, 4, s. 355-359

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2001
  36. A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes

    K Strandberg, P Bhiladvala, Johan Holm & Johan Stenflo, 2001, I: Blood Coagulation and Fibrinolysis. 12, 7, s. 503-510

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 2000
  38. Structural model of human alpha1-microglobulin: proposed scheme for the interaction with the Gla domain of anticoagulant protein C

    B O Villoutreix, B Akerström & A Lindqvist, 2000 apr, I: Blood Coagulation and Fibrinolysis. 11, 3, s. 261-75

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. NovoSeven in warfarin-treated patients

    Erik Berntorp, L Stigendal, Stefan Lethagen, L Olofsson & U Hedner, 2000, I: Blood Coagulation and Fibrinolysis. 11, Suppl 1, s. S113-S115

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Structural model of human alpha-1-microglobulin: p

    B Villoutreix, Bo Åkerström & A Lindqvist, 2000, I: Blood Coagulation and Fibrinolysis. 11, 3, s. 261-275

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. 1999
  42. Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin

    Anders Gottsäter, I. Anwaar, P. Lind, I. Mattiasson & F. Lindgärde, 1999, I: Blood Coagulation and Fibrinolysis. 10, 3, s. 133-140 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Oubain role on erythrocyte/fibrinogen interaction

    Isabel Goncalves, Rui Mesquita, C Saldanha & J Martins e Silva, 1999, I: Blood Coagulation and Fibrinolysis. 10 , Suppl 1, s. S107

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  44. 1994
  45. Low-molecular-weight heparin (Fragmin) versus heparin for anticoagulation during cardiopulmonary bypass in open heart surgery, using a pig model

    L Bagge, T Wahlberg, E Holmer, H Tydén, S O Nyström & T Malm, 1994 apr, I: Blood Coagulation and Fibrinolysis. 5, 2, s. 265-72 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers

    J. Holst, B. Lindblad, D. Bergqvist, K. Garre, H. Nielsen, U. Hedner & P. B. Ostergaard, 1994, I: Blood Coagulation and Fibrinolysis. 5, 5, s. 795-803

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. 1993
  48. Report of a joint WHO/WFH meeting on the control of haemophilia: Carrier detection and prenatal diagnosis

    I.R. Peake, D.P. Lillicrap, V. Boulyjenkov, E. Briet, V. Chan, E.K. Ginter, E.M. Kraus, R. Ljung, P.M. Mannucci, K. Nicolaides & E.G.D. Tuddenham, 1993 nov 25, I: Blood Coagulation and Fibrinolysis. 4, 2, s. 313-344 32 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. 1991
  50. No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin

    Thomas Mätzsch, D Bergqvist, A Bergqvist, S Hodson, J Dawes, U Hedner & P Ostergaard, 1991, I: Blood Coagulation and Fibrinolysis. 2, 2, s. 273-278

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. The influence of surgical trauma on factor XaI and IIaI activity and heparin concentration after a single dose of low-molecular-weight heparin

    Thomas Mätzsch, D Bergqvist, U S Burmark, E Holmer & K Soderberg, 1991, I: Blood Coagulation and Fibrinolysis. 2, 5, s. 651-657

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. 1990
  53. The effect of unfractionated and low-molecular-weight heparin on the release of prostacyclin from the arterial wall

    J Brunkwall, Thomas Mätzsch & D Bergqvist, 1990, I: Blood Coagulation and Fibrinolysis. 1, 6, s. 641-645

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift